People | June 22, 2024
AbbVie appoints Roxanne S. Austin as Lead Independent Director of the Board of Directors
Austin assumes role from Glenn F. Tilton, who will continue to serve as an independent director
Austin assumes role from Glenn F. Tilton, who will continue to serve as an independent director
Second FDA approval for KRAZATI - reinforcing its potential across tumor types
Zealand Pharma anticipates initiation of a Phase 2b clinical trial in H2 2024
DSP-5336, an Investigational Menin and Mixed-lineage Leukemia Inhibitor, is Being Evaluated in Patients with Relapsed or Refractory Acute Leukemia
India's healthcare sector anticipates telemedicine reaching US$ 5.4 billion by 2025, with AI growing at 45% by 2024 and Healthtech jobs increasing 15-20%
Co-founder and previous CEO Lowry Curley becomes Chief Scientific Officer
Glenmark's current portfolio consists of 197 products authorized for distribution in the U.S. marketplace
DurA Cycle is designed for large-scale commercial manufacturing of monoclonal antibodies,
The transaction aligns with Lupin's strategy to grow its global presence in Specialty areas
Updated analysis from Memorial Sloan Kettering Cancer Center presented at ASCO 2024 has expanded to 42 patients with clinical complete response
Subscribe To Our Newsletter & Stay Updated
